1 RAPS ONLINE UNIVERSITY Practical education and training for business success. For regulatory professionals, there is only one name to know and trust for online education and training RAPS Online University.
2 RAPS ONLINE UNIVERSITY Essential knowledge. Well earned. RAPS Online University was developed to deliver comprehensive learning to busy regulatory professionals like you. The immersive format puts you inside real-world scenarios that build your knowledge and establish best practices for better decision making. Top 3 Reasons to Choose e-learning with RAPS Online University Unique regulatory-focused education that serves as a costeffective alternative to traditional, in-person training 24/7 access to programs and courses, available from your laptop, ipad or Android Relevant and timely course curricula continually adapted to address today s regulatory requirements 94% of customers surveyed would recommend RAPS Online University courses and certificate programs to a colleague.
3 REGULATORY AFFAIRS CERTIFICATE PROGRAMS This unique series of courses gives you the knowledge and expertise you need to advance your career. Build your customizable curricula of online courses around medical devices, pharmaceuticals or both. Regulatory Affairs Certificate: Medical Devices Gain a better understanding of the medical devices industry, enhance your resume or train your whole team. The Medical Devices certificate includes nine interactive courses that cover the essentials of medical device regulation. Start with the required core courses: Ethics Global Regulatory Strategy for Medical Devices Medical Devices: Definition & Lifecycle Role of the Regulatory Professional Then add five more courses from our extensive list of electives that meet your specific needs and goals. Member: $2,100 Enterprise Member: $1,890 List price: $2,625 Regulatory Affairs Certificate: Pharmaceuticals Cost-effective and convenient, the Pharmaceuticals certificate equips you or your organization s team with the tools and knowledge needed to progress as a regulatory professional and stay ahead of the competition. Whether you re new to pharmaceuticals, transferring from a related area or just brushing up, gain the skills you need in just nine courses. Start with the required core courses: Ethics Global Regulatory Strategy for Pharmaceuticals Pharmaceuticals: Definition & Lifecycle Role of the Regulatory Professional Then add five more courses from our extensive list of electives to meet your specific needs and goals. Member: $2,100 Enterprise Member: $1,890 List price: $2,625 Regulatory Affairs Certificate: Medical Devices and Pharmaceuticals (Dual) This comprehensive program combines key components of both the Medical Devices and Pharmaceuticals certificate programs. Six core and eight elective courses capture the essentials of both fields in a single flexible program. Any course in the catalog qualifies as an elective. Member: $3,300 Enterprise Member: $2,970 List price: $4,125 GROUP RATES and let us help you create a package that meets the training needs of your team or organization.
4 CERTIFICATES AND CERTIFICATIONS Certificate program. Certification program. The names sound similar, but the features of these programs and the benefits they provide are quite different. Understanding the differences between certificate and certification programs, such as the RAPS Regulatory Affairs Certification (RAC), will help you make an informed decision about which program will best meet your professional development needs. Certificate Results from an educational process For both newcomers and experienced professionals alike Awarded by educational programs or institutions Indicates completion of a course or series of courses with a specific focus Demonstrates knowledge of course content at the end of a set time period Certification Results from an assessment process Typically requires some amount of professional experience Awarded by a third-party, standard-setting organization Indicates mastery/competency as measured against a set of standards, usually by application and/or exam Standards set through an industry-wide process Typically results in a designation to use after one s name, e.g., RAC Has ongoing requirements in order to maintain; holder must demonstrate s/he continues to meet requirements The flexibility of choosing electives modules to fit my own interests and the basic module helps to strengthen the foundation basics required to perform my job duties. It has been an enriching experience as it broadens my expertise and deepens my knowledge in the regulatory world. - Audrey Lee, Regulatory Affairs Specialist, Singapore
5 RAPS ONLINE UNIVERSITY BUNDLES RAPS course bundles consist of relational topics that intersect in practice. These important and relevant compilations deliver reliable and focused content, at an affordable rate. GxP Bundle The topics included in this bundle provide the foundation for product quality critical knowledge for new professionals in regulatory, quality assurance, compliance or related departments such as laboratory management or clinical operations. Bundle Courses Good Clinical Practice (GCP) Good Laboratory Practice (GLP) Good Manufacturing Practice (GMP) Member: $795 List price: $1,115 Medical Devices Postapproval Bundle Intended for experienced regulatory, quality systems, medical affairs, legal, compliance management and product development engineering personnel, this set of courses provide an examination of the applicable regulations, requirements and health authority reporting criteria across the US, Canada and EU. Bundle Courses Medical Devices: Corrections, Removals and Directed Recalls Medical Devices: Postmarket Surveillance Medical Devices: Risk Management Member: $1,120 List price: $1,560 Regulatory Basics Bundle This bundle provides fundamental information on product lifecycles, gives insight into professional roles and responsibilities and discusses regulatory mechanisms, processes and agencies within key markets. Combined, these courses serve as an excellent foundation for regulatory affairs knowledge. Bundle Courses Pharmaceuticals: Definition and Lifecycle Medical Devices: Definition and Lifecycle Role of the Regulatory Professional Introduction to Regulatory Affairs in the EU Introduction to Regulatory Affairs in the US and Canada This bundle is available in three options, based on regions. Complete Member: $500 List price: $700 US/CAN Member: $400 List price: $560 EU Member: $320 List price: $440
6 Clinical Trial Foundations Bundle Improve your knowledge concerning the proper conduct of clinical research with human subjects. Learn more about the fundamental requirements for major markets, the role of the informed consent process, types and phases of clinical trials and protocol development, roles and responsibilities of parties involved in clinical research and issues related to trial management and safety monitoring. Bundle Courses Good Clinical Practice (GCP) Understanding and Managing the US Clinical Trial Process Clinical Trials Primer for Regulated Pharmaceuticals (On-demand Webcast) Member: $924 List Price: $1,296 Regulatory Medical Writing Bundle Regulatory and medical writing is an integral part of the product development and approval process. It is a skill that must be honed and refined as you gain regulatory knowledge and experience. Learn more about the components of various application types and techniques for improving document quality. This bundle is offered in five different packages. Review the options below and select which one is right for you. Introductory Medical Writing Intermediate Medical Writing: Investigational Applications Intermediate Medical Writing: Pharmaceuticals and Biologics Intermediate Medical Writing: Medical Devices Complete Package 1 Package 2 Package 3 Package 4 Member Price $1,164 $976 $896 $896 $724 List Price $1,632 $1,368 $1,256 $1,256 $1,016
7 COMPLETE COURSE DIRECTORY RAPS Online University provides you with education options to hone your skills in your area of expertise. Individual courses on a variety of regulatory topics, from the basics to product- and region-specific subjects, including regulatory essentials, clinical, medical devices, pharmaceuticals and quality were all developed to challenge your knowledge and provide the information you need to do your job better. MD Purchase individually or as part of the Regulatory Affairs Certificate: Medical Devices P Purchase individually or as part of the Regulatory Affairs Certificate: Pharmaceuticals ESSENTIALS Effective Regulatory Communication MD P Gain a perspective on the critical elements in effective communication from the regulatory professional s point of view, from influencing teams to managing meetings, as well as everyday activities within and across the company. Ethics MD P Identify and analyze ethical issues as they relate to complex concepts and theories, including bioethics and legal principles. Ethical issues in areas of product development, compliance and clinical testing are highlighted. FDA Law and Regulation MD P This course provides insight into FDA regulatory reform and the initiatives FDA is undertaking to create a globally harmonized regulatory scheme for food, drug, device and cosmetic products. Intermediate Medical Writing: Biologics and Pharmaceuticals P This course focuses on the Common Technical Document (CTD) and includes a breakdown of regionspecific considerations for clinical sections of the NDA, BLA and MAA. Intermediate Medical Writing: Investigational Applications MD P Learn a variety of investigational applications prepared by regulatory and medical writers for both drugs/ biologics and medical devices, including IND, CTA, IDE, ITA and IMPD. Intermediate Medical Writing: Medical Devices MD This course looks at key sections of the Premarket Approval (PMA) and 510(k) Premarket Notification applications for medical devices in the US. Introduction to Regulatory Affairs in the EU MD P Focus on the development of healthcare product regulation in the EU and the responsibilities of agencies involved, processes employed and interactions among agencies. Gain a basic understanding of the regulatory requirements for obtaining marketing approval for healthcare products.
8 Introduction to Regulatory Affairs in the US and Canada MD P This course examines healthcare product regulation across product lines in North America, specifically in the US and Canada. It highlights the agencies primarily responsible for regulating healthcare products FDA and Health Canada. The course reviews the applicable legislation that drives the regulatory processes. Introductory Medical Writing MD P Take a look at the medical writing profession from a regulatory perspective, including an introduction to the basic skills important for medical writing in regulatory. Project Management for Regulatory Professionals MD P Learn how to effectively establish a regulatory development project plan, including identifying resources and determining the effort and time required to create projects and budget reports. Regulatory Due Diligence for Product Development MD P Gain a basic understanding of the principles and practices of due diligence within the medical product environment. The processes and checklists commonly used in due diligence also are discussed and put into practice using a hypothetical case study. The Role of the Regulatory Professional MD P Discuss the evolution of the regulatory profession and the professional s roles and responsibilities. The course also outlines critical events and their impact for each product lifecycle stage for drugs, biologics and medical devices. Supplier Management MD P Get a basic understanding of supplier management practices and their impact on product quality and patient safety. Upon completion, you will understand the key risks associated with suppliers and the best way to help your organization as a regulatory professional. Supply Chain Controls MD P Review common supply chain issues, key steps in supply chain control and ways FDA encourages organizations to improve their supply chain controls through guidance documents and regulatory harmonization activities. It is recommended that you have a working knowledge of supplier qualification and management before taking this course.
9 MEDICAL DEVICES Global Regulatory Strategy for Medical Devices MD Become familiar with guidelines for developing successful global strategies for medical devices, including definitions and classifications worldwide, elements of regulatory strategy, sources of competitive and regulatory intelligence, selection of development and product approval pathways and suggestions for professional development. Medical Devices: Advertising and Promotions in the US MD This course provides information on the US agencies that regulate medical devices, their enforcement tools, as well as strategies to avoid enforcement actions. Included are guidelines for a regulatory review of medical device advertising, methods used to identify claims in promotional materials and evaluating evidence to substantiate various types of claims. Medical Devices: Canadian Regulations MD This course addresses a wide range of issues, from the regulatory framework provided by Health Canada and the steps to submit an investigational testing application (ITA) or a medical device license application to postmarket activities. Medical Devices: China, Japan, Singapore and South Korea Regulation Overview MD Examine medical device regulations and registration in China, South Korea, Japan and Singapore. You will learn how to effectively plan a submission, and actively manage potential registration or compliance issues. Medical Devices: Compliance and Audits MD Review the background on auditing practice and the evolution of the requirements for medical devices, from a regulatory point of view, and look at applicable medical device regulations. Medical Devices: Corrections, Removals and Directed Recalls MD Examines the definitions of recall classifications and types, and explains them, with emphasis on the importance of the recall strategy, planning, communication, reporting and recordkeeping. Medical Devices: Definition and Lifecycle MD This course is a primer a basic introduction to medical devices and general aspects of product and regulatory lifecycles. It also provides a brief history of medical device regulation and information on basic regulatory principles and concepts as they apply to medical devices. Medical Devices: EU Regulations MD Gain a strong foundation of the key elements of the EU directives governing medical devices, including the Active Implantable Medical Devices Directive (AIMDD) 90/385/EEC, Medical Devices Directive (MDD) 93/42/EEC and In Vitro Diagnostic Devices Directive (IVDD) 98/79/EC in their latest revision, including the 2007/47/EC amendments to AIMDD and MDD. Medical Devices: Postmarket Surveillance MD This course highlights the requirements and importance of an effective postmarket surveillance program that satisfies the regulatory and quality system requirements in the US, Canada and EU.
10 Medical Devices: Risk Management MD This course is not intended for implementing Enterprise Risk Management, but is oriented to product safety risk management. Throughout the course, the focus is on product safety for people (not just the patient), property and the environment. Medical Devices: US Regulations MD Examine a wide range of medical device regulation issues, from the history of medical device regulation, through the steps required to submit an application to FDA for approval (or clearance) to market a device and address postmarket requirements. Regulation of Combination Products in the US MD See an historic perspective on combination product regulation in the US. Examine the current regulations and policies covering the identification, jurisdiction and review of combination products including, premarket activities, applicability of Good Manufacturing Practices and postmarket requirements, such as adverse event reporting, inspection and enforcement. Regulation of IVDs for Key International Markets MD This course will cover IVD regulatory requirements in three key markets Europe, Canada and Japan. Topics within each market include IVD risk classifications, manufacturer s premarket responsibilities, labeling requirements and postmarket surveillance requirements. The unique regulatory structure in each market will be examined, with clear directions regarding the process for obtaining market clearance. Regulation of IVDs in the US MD Review in vitro diagnostic medical devices with a focus on FDA s regulatory requirements. This course introduces key regulations and guidelines necessary for effective product development, explains what IVDs are and describes development and testing, getting a product to market, product review and FDA submission requirements. I was able to learn many things about the regulated industries that I couldn t otherwise. The self-paced and interactive courses made the information much more appealing. This was a great learning experience for me. -Juan Figueroa, Process Transfer Senior Manager, USA
11 PHARMACEUTICALS Chemistry, Manufacturing and Controls (CMC) P Review the CMC section of dossiers and discuss the CMC information necessary to support investigational applications and information on CMC specific guidances including Drug Master Files (DMFs). Global Regulatory Strategy for Pharmaceuticals P This course provides a look at regulatory considerations in pursuing marketing approval in the major regions of the world and compares the application requirements in these regions. Pharmaceuticals: Advertising and Promotional Labeling in the US P This course outlines the regulatory framework for prescription drug and biologic promotional materials by examining FDA regulations and issues involved in producing compliant promotional materials. Practical aspects for the review of promotional materials will be provided, along with key evidentiary standards required to substantiate claims. Emerging trends in promotion (i.e., use of social media) will also be discussed. Pharmaceuticals: Canada Regulations P During this course, participants learn about the Canadian regulatory framework and applicable legislation for prescription drugs, nonprescription drugs and natural health products (NHPs). Pharmaceuticals: Compliance and Audits P Gain knowledge of fundamental good quality auditing practices and skills. This course is intended to provide background information on auditing practice and the evolution of the requirements from a regulatory point of view, with a review of the applicable regulations. Pharmaceuticals: Definition and Lifecycle P Learn the basic terminology used in the pharmaceutical industry, as well as key regulatory principles and processes governing the stages in the development of a pharmaceutical product, including early-stage research, nonclinical and clinical trials, manufacturing, marketing and postmarketing. Pharmaceuticals: EU Regulations P This course describes the different EU application and registration procedures, followed by an explanation of the regulatory requirements for a product s lifecycle, including marketing and postmarketing requirements and the switch to over-the-counter status. The enforcement of regulations through inspections and other compliance activities is also addressed. Pharmaceuticals: US Regulations P Examine the history of pharmaceuticals in the US, the requirements to obtain prescription and overthe-counter drug approvals, and other requirements that are in place to ensure compliance with FDA regulations, such as pharmacovigilance reporting.
12 Pharmacovigilance P This introductory course looks at pharmacovigilance across a spectrum of topics, presenting both US and global perspectives. Participants learn the basic concepts, regulatory requirements and recent trends and approaches, to understanding and communicating a safety profile. Regulation of Biosimilars P The major part of this course compares the current 2013 guidances discussing the quality, nonclinical and clinical aspects of biosimilar development from three major regulatory jurisdictions: the EU, US and Canada. Regulation of Combination Products in the US MD P Examine the historic perspective on combination product regulation in the US. This course reviews the current regulations and policies covering the identification, jurisdiction and review of combination products. It also covers premarket activities, applicability of Good Manufacturing Practices and postmarket requirements, such as adverse event reporting, inspection and enforcement. Regulation of Dietary Supplements and NHPs P This course provides an explanation of the regulatory requirements for dietary supplements in the US and natural health products (NHPs) in Canada. Regulation of Generic Drugs in the US P Cover a broad range of topics, including the concepts of bioequivalence and therapeutic equivalence, the role and mechanics of patents and nonpatent marketing exclusivity, application components, postapproval maintenance and the new generic drug user fee requirements. Regulation of US and EU Biologics P This course introduces various aspects specific to biologics manufacturing, nonclinical and clinical development and some global regulatory considerations that add further complexity (e.g., e-submission). Risk Evaluation and Mitigation Strategies (REMS) and Risk Management Plans (RMPs) P This course looks at the history of risk management, reviews risk management philosophies and examines regulatory requirements and interactions between industry and regulators in the US, EU and Canada. It discusses methods for conducting successful risk management programs and developing an organization to support lifecycle safety and explores the future of risk management.
13 QUALITY Good Laboratory Practice (GLP) MD P This course outlines the role of regulatory bodies involved in creating and improving GLPs with the goal of achieving human safety. It also provides an understanding of how GLPs fit into a quality system, what types of studies are covered and how GLPs in the US and international market align. Good Manufacturing Practice (GMP) P Review a wide range of issues, including why regulations were created and are enforced worldwide, how pharmaceutical companies ensure compliance with the regulations, reasons for making quality products, US and EU regulations, the consequences for failing to comply with any regulations and associated regulatory actions. Quality System Regulation (QSR) MD This course is designed to align with the organization of the subparts and paragraphs as presented in the Quality System Regulation (QSR). You ll take a look at the background and history of the QSR, essential elements of an acceptable quality system, applicability and/or exemption of QSR paragraphs to certain cases and the minimum regulatory requirements for manufacturing and marketing medical devices in the US. CLINICAL Globalization of Clinical Research Trials and Investigations MD P During this course you will be introduced to the historical background and current regulatory requirements for conducting pivotal clinical trials in three countries that are often discussed as critical for global registration China, India and Japan. Key challenges for the creation of global regulatory and clinical development plans are reviewed, along with a discussion of the essential components required to meet Good Clinical Practice (GCP) and regulatory expectations for the conduct of a global trial. The logistics that are central to the conduct of multinational trials will also be discussed. Good Clinical Practice (GCP) MD P During this course, you learn what led to the need for GCPs and gain an understanding of the overall goals of GCPs. Because GCPs are international guidelines, the cooperation and collaboration between FDA and other regulatory agencies also are explored. Understanding and Managing the US Clinical Trial Process MD P The types and phases of clinical trials and protocol development, as well as key issues related to clinical trial management and monitoring, are reviewed from a regulatory perspective.
14 Demand Better. Get RAPS On-Demand Webcasts & Programs. Regulatory knowledge and information on your schedule. Convenient, cost-effective regulatory knowledge and information is waiting for you. RAPS offers you convenient and cost-effective access to our extensive library of on-demand content, presented by industry experts. Expand your knowledge on critical regulatory areas or brush up on the latest hot topics. Check out our latest popular on-demand releases: ON-DEMAND PROGRAM FDA Hot Topics: Update on Medical Device Guidances VIRTUAL PROGRAM ON-DEMAND WEBCAST Advertising and Promotion for Prescription Drugs and Biologics New China Medical Device Regulations: Review of Impact to Date and Best Practices for Clinical Trials Strategies for Your Career: Finding YOUR Pathway into Regulatory Affairs FREE WEBCAST
15 Corporate Solutions Give your organization access to global regulatory education and information developed by leading regulatory experts. RAPS offers corporate/group rates for: RAPS Online University courses Regulatory Affairs Certificates Advantages & Benefits Subscription options for small teams or enterprise-wide SCORM compliant (online courses) Course integration with corporate LMS (conditions apply) Need More Information? For more information or to speak with a RAPS representative about your organization's needs, contact our Business Development Team at , ext. 228 or visit RAPS.org/smartorgs
16 5635 Fishers Lane Suite 550 Rockville, MD USA RAPS ONLINE UNIVERSITY Essential knowledge. Well earned.
Life Sciences Medical Product Development Certificate Program Accelerate Your Career extension.uci.edu/mpd In today s competitive business environment, leaders are appointed based on credentials and experience.
Regulatory Affairs Professional Development Framework AN OVERVIEW TABLE OF CONTENTS Abstract...2 Introduction...2 Approach...3 Professional Development Framework...3 Professional Levels...3 Domains...4
Total Product Lifecycle Solutions from NSF Health Sciences Medical Devices Experts in medical device quality systems, compliance, regulatory affairs, auditing and training www.nsf.org The Right People.
School of Pharmacy TEMPLE UNIVERSITY Regulatory Affairs and Quality Assurance Graduate Program Te mple Unive rsity School of Pharmacy Re gulatory Affairs and Quality Assurance Graduate Program 4 25 Comme
Clinical evaluation Latest development in expectations EU and USA Medical Devices: staying ahead of regulatory developments Gert Bos BSI Israel 22 April - Herzliya Copyright 2012 BSI. All rights reserved.
CHAPTER TWO Global affairs role in the biopharmaceutical industry 2.1 Overview 2.2 Global affairs organization 2.3 Role of global affairs 2.4 Key functions and activities 2.5 Global strategy 2.6 Global
RAC (US) Examination Study Checklist Instructions: Use this checklist to track your progress when preparing for the RAC (US) certification examination. When you begin your studying, each task statement
LIBRARY GUIDE: Clinical Pharmaceutical Table of Contents Overview...2 Course Descriptions Core Knowledge: A Tour of the FDA (PHDV60)...4 A Tour of Health Canada (PHDV89)...4 A Tour of Health Europe (PHDV90)...4
RAC (Global) Examination Study Checklist Instructions: Use this checklist to track your progress when preparing for the RAC (Global) certification examination. When you begin your studying, each task statement
NRA FUNCTION IN CONTROLLING VACCINES IN CLINICAL TRIAL AND MARKETING AUTHORIZATION INDONESIA 2013 DVI MEETING 9 11 APRIL 2013 1 2 The National Agency of Drug and Food Control (NA-DFC) is a non departmental
Temple University - School of Pharmacy 425 Commerce Drive, Suite 175 Fort Washington, PA 19034-2713 Phone: 267.468.8560 Fax: 267.468.8565 CERTIFICATE IN CLINICAL TRIAL MANAGEMENT Designed for Pharmaceutical
WHITEPAPER: SOFTWARE APPS AS MEDICAL DEVICES THE REGULATORY LANDSCAPE White paper produced by Maetrics For more information, please contact global sales +1 610 458 9312 +1 877 623 8742 firstname.lastname@example.org
Roles & Responsibilities of the Sponsor Developed by Center for Cancer Research, National Cancer Institute, NIH Endorsed by the CTN SIG Leadership Group Objectives Funding for clinical research comes from
Temple University - School of Pharmacy 425 Commerce Drive, Suite 175 Fort Washington, PA 19034 Phone: 267.468.8560 Fax: 267.468.8565 BACKGROUND MEDICAL DEVICE CERTIFICATE An Overview of Global and Domestic
How to Manage Regulatory Issues and get FDA Approvals Maureen Garner, President Glenn Neuman, Director of Scientific Affairs New World Regulatory Solutions, Inc. www.newworldreg.com 1 About NWRS New World
Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE Dr. Fulvio CARLOTTI, GNOSIS SpA, Corporate QA Director September 26, 2014 Scope of GMP GMP compliance
Medical Devices Notified Bodies and the CE certification Process for Medical Devices European Surgical Robotics Demonstration Day 27 th March 2014, Leuven, Belgium 1 Bart Mersseman Product Manager Medical
FDA Regulation of Medical Devices Bradley Merrill Thompson Interpharm Press, Inc. Buffalo Grove, IL Dedication Acknowledgments Introduction xv xvi xvii Part I. Overview Chapter 1. The History of Medical
CONSUMER TESTING SERVICES ELECTRICAL & ELECTRONICS ELECTRO MEDICAL DEVICES ELECTRO-MEDICAL DEVICES IN TRUSTED HANDS SGS IS THE WORLD S LEADING TESTING AND CERTIFICATION COMPANY 1 SGS MEDICAL NETWORK: THE
Med-Info Regular Information Bulletins for the Medical Device Industry Product Service Globalization of Medical Device Approval Mutual Recognition Agreements (MRA) between the EU and the USA and Australia
IVD Regulation Overview Requirements to Assure Quality & Effectiveness CLIAC Jan. 2002 Statutory and Regulatory Requirements Statute: Food, Drug, and Cosmetic Act Food and Drugs Act of 1906 Food and Drug
> Raising the Bar QA AND RA EXPERTS RAISING THE BAR TO HELP YOU ACHIEVE REGULATORY COMPLIANCE Team We have worked with Complya for several years on clinical and GMP auditing projects and found Jonathan
Guidance s Distribution Requirements and Inclusion in Risk Evaluation and Mitigation Strategies (REMS) U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation
WHITE PAPER Optimizing Drug Registration in China: Category I Route ppdi.com April 2013 EXECUTIVE SUMMARY With a population of 1.3 billion and a pharmaceutical market growing at nearly 20 percent per year,
QUALITY RISK MANAGEMENT COMPETITIVE ADVANTAGE EXPERTISE FURTHER EXCELLENCE MARKET INTELLIGENCE REGULATORY COMPLIANCE SPEED TO MARKET PATIENT SAFETY MEDICAL DEVICES FIND THE FASTEST AND MOST RELIABLE ROUTE
Importing pharmaceutical products to China Imported pharmaceutical products need pre-market approval before entering the Chinese market Imported drugs for human use are required to obtain pre-market approval
EU DIRECTIVE ON GOOD CLINICAL PRACTICE IN CLINICAL TRIALS DH & MHRA BRIEFING NOTE Purpose 1. The Clinical Trials Directive 2001/20/EC heralds certain additional responsibilities for the Medicines and Healthcare
Temple University - School of Pharmacy 425 Commerce Drive, Suite 175 Fort Washington, PA 19034 Phone: 267.468.8560 Fax: 267.468.8565 POST-MASTER S CERTIFICATES in ADVANCED QUALITY ASSURANCE or REGULATORY
Med-Info International expert information for the Medical Device industry Introduction to Korean Medical Device regulations The Ministry of Health and Welfare (MHW) is the healthcare agency having overall
Regulations for Handling Samples and Laboratory Testing from R&D through Phase III Clinical Trials Ron Hinkel, Director Quality Systems BioReliance Inc. Patti Rossman, President Globiox Purpose Keep pace
Transformation towards a New Regulatory Paradigm Risk Management Plan (RMP) on Biologicals and NCE Junko SATO International Coordination Officer PMDA, Japan 1 2 Pharmaceuticals and Medical Devices Agency
Regulatory Submission: Applying GLP in Surgical Efficacy Studies Curtis Schondelmeyer, DVM Director Preclinical Veterinary Services and Efficacy and Surgical Research Services Welcome to Toxikon 2 CONFIDENTIAL
Medtec Ireland 2015 Wireless Medical Devices Regulatory Considerations for Medical Device Software Kenneth L. Block, RAC October 7, 2015 Galway, Ireland Offices: Dallas, Texas (12 employees) Tokyo, Japan
UNDERSTANDING THE EC DIRECTIVE 98/79/EC ON IN VITRO DIAGNOSTIC MEDICAL DEVICES A WHITE PAPER ON THE REQUIREMENTS, REGULATIONS AND OPPORTUNITIES CONTAINED IN EC DIRECTIVE 98/79/EC AND A BRIEF COMPARISON
Data Standards Program Action Plan Version: 2.2 Document Date: May 25, 2016 REVISION HISTORY Version Number Implemented By Revision Date Description of Change 1.0 CDER DSPB February 21, 2013 Initial Document
Overview of Drug Development: the Regulatory Process Roger D. Nolan, PhD Director, Project Operations Calvert Research Institute November, 2006 Adapted from course taught by Cato Research Background: Roger
Course Description: This course is an in depth review of the history, authorizing statute and regulatory authority of US FDA and the influence and impact of FDA on science and health policy. Drug development,
Career Opportunities at FDA From a regulatory scientist perspective Ke Zhang, Ph.D. U.S. Food and Drug Administration Silver Spring, MD Disclaimers 1. The views expressed in this presentation are those
School of Pharmacy TEMPLE UNIVERSITY Regulatory Affairs and Quality Assurance Graduate Program Te mple Unive rsity School of Pharmacy Re gulatory Affairs and Quality Assurance Graduate Program 4 25 Comme
100 HOT TOPICS FOR DISSERTATION FOR PG DIPLOMA/ DEGREE IN REGULATORY AFFAIRS Mr. R.M. Gupta (M. Pharm.), is a free lancer consultant for US DMF, COS, ANDA, ACTD, CTD, ectd and he is also the director of
FDA Basics For Biotech Drugs, Biologics and Devices I. FDA Overview A. FDA has authority over products intended for the diagnosis, treatment or mitigation of human disease or intended to affect a structure
Mobile Medical Application Development: FDA Regulation Mobile Medical Applications: Current Environment Currently over 100,000 mobile health related applications are available for download; there is an
Competent Authority, Related Organization Laws Regulations License /or Registration of each type of Business Population: 127 million Ministry of Health, Labor Welfare( MHLW), -Pharmaceutical Food Safety
The regulation of medical devices in Europe Role of Standards Mireille De Cré, Pharm D MDCPartners Mireille.email@example.com Design, trials, manufacturing Surveillance audits, Regulatory requests Regulatory
Course Certificate In Pharmaceuticals and Medical Research: Clinical Research Monitoring & Coordination Welcome to the latest in distance learning courses designed to prepare you, on your own schedule,
Vigilance Reporting for Medical Devices in the EU By Salma Michor, PhD, RAC 24 September 2009 Manufacturers putting medical devices on the market in the European Union (EU) must have a vigilance system
ICH and Singapore Dr Christina Lim Deputy Group Director, Health Product Regulation Group Senior Advisor, International Collaboration Health Sciences Authority Singapore November 2008 Overview Health Science
Personal Data Name Title Validation Consultant Contact jsb-validierung Zwischen den Bächen 9 D 79618 Rheinfelden Tel: +49 7623 79 49 82 Mobile: +49 172 737 84 86 E-Mail: Internet: firstname.lastname@example.org http://www.jsb-validierung.de
Update: Proposed Medical Device Regulation (MDR) & IVD Regulation (IVDR) Paul Brooks Healthcare Solutions Disclaimer The new regulations are not finalized and subject to change http://medicaldevices.bsigroup.com/en-us/resources/whitepapers-and-articles/
Guidance for Industry Format and Content of Proposed Risk Evaluation and Mitigation Strategies (REMS), REMS Assessments, and Proposed REMS Modifications DRAFT GUIDANCE This guidance document is being distributed
Global Good Manufacturing Practice A Comparability Study to Link Good Manufacturing Practice Standards for World Wide Compliance Within the Cellular Therapy Industry Presented by Rosemarie Bell 24 April
How companies leverage quality and quality certifications to achieve competitive advantage Eize de Boer Systems & Services Certification International Business Development Manager Pharma Supply Chain for
Combination Products Regulation in the United States Presenter: Scott Sardeson RAC US/EU 3M Health Care St. Paul, MN USA 1 Presentation Outline Combination products Definitions and Regulations Jurisdiction
School of Pharmacy TEMPLE UNIVERSITY Regulatory Affairs and Quality Assurance Graduate Program Te mple Unive rsity School of Pharmacy Re gulatory Affairs and Quality Assurance Graduate Program 4 25 Comme
Library Guide: Pharmaceutical GMPs Table of Contents Overview...3 Courses Listed by Functional Area... 4 Course Descriptions: A Step-by-Step Approach to Process Validation (PHDV79)... 7 A Tour of the FDA
GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group email@example.com Common Misconception Good Laboratory Practices 1) A quality system concerned with the organizational process
Regulatory Affairs Graduate Postgraduate Program Novartis Pharma AG Novartis Animal Health AG The Regulatory Affairs (RA) Graduate Program is an opportunity to discover the global functions of Drug Regulatory
Guidance for Industry Q10 Pharmaceutical Quality System U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation
History and Principles of Good Clinical Practice Cristina E. Torres, Ph.D. Social Science Professor, UPM-NIH FERCAP Coordinator ICH: International Conference on Harmonization GCP: Good Clinical Practices
1. Introduction REGULATORY ENVIRONMENT Research and development work, pre-clinical tests, clinical studies, facilities, and the manufacture and sale of the Company s products are and will continue to be
EUROPEAN INDUSTRIAL PHARMACISTS GROUP Guide to Good Regulatory Practice Acknowledgments: Valérie LACAMOIRE, Conseil Central de la section B de l Ordre des Pharmaciens Kelsey MOWER, Industrial Pharmacists
Regulatory Affairs and Quality Assurance Graduate Program Temple University School of Pharmacy Regulatory Affairs and Quality Assurance Graduate Program 425 Commerce Drive, Suite 175 Fort Washington, PA
2014 ISCT-GRP Workshop Session I Welcome to PIC/S: Regulatory implications of migration Ellen, Ying-Hua Chen Section Chief / GMP Inspector Food and Drug Administration Ministry of Health and Welfare Taiwan
Regulatory Challenges in the Development of Diagnostic Tests Industry Perspective Brad Spring Director, Regulatory Affairs September 28, 2011 Balancing Evidence of Safety & Effectiveness and Time to Market
2012/CTI2/MAG/WKSP/011 Regulatory Framework for Control of Refurbished Medical Devices Submitted by: GE Healthcare Workshop on Remanufacturing Research and Development in APEC Economies Singapore 28 March
Understanding the International Medical Device Regulatory Process MAE Consulting Group LLC Janet Kwiatkowski President August 7, 2013 Topics Understanding the three types of countries in terms of regulation
ORACLE CONSULTING GROUP An Official United States Agent Firm for Foreign Establishments CONSULTING MEMORANDUM: DEALING WITH A MEDICAL DEVICE IN THE U.S. 5398 Golder Ranch Rd., Ste. 1 Tucson, Arizona 85739
1.2 - Overview of Regulation of Clinical Trials in Canada Presentation to APEC Preliminary Workshop on Review of Drug Development in Clinical Trials Celia Lourenco, PhD, Manager, Clinical Group I Office
Your Health and Safety... Our priority Votre santé et votre Securité notre priorité Health Canada s GCP Compliance Program GCP Information Sessions November 2010 Objective To describe the role that Health
Regulatory oversight of drug clinical trial in China Wang Jianan CFDI-CFDA firstname.lastname@example.org 2014.9,Berlin 1 Outline Brief introduction of CFDA/CFDI Relevant laws and regulations Supervision of drug clinical
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 January 12, 2016 Amy
An FDA Perspective on Post- Approval Change Management for PAT and RTRT IFPAC 2015 January 26, 2015 Christine M. V. Moore, Ph.D. Acting Director, Process and Facilities FDA/CDER/OPQ Post-Approval Changes
Health and Medical Field (Objectives and perspectives for regulatory reform) Achieving a healthy society of longevity Improving public convenience Industrial development and economic revitalization Fiscal
INTRODUCTION This book offers a systematic, ten-step approach, from the decision to validate to the assessment of the validation outcome, for validating configurable off-the-shelf (COTS) computer software
Clinical Research Associate (CRA) - A Growing Career Path in Biotechnology / Pharmaceutical Industry By http://www.clinicalresearchassociate cra.com/studyguide/ A clinical research associate (CRA) is a
NBOG s Best Practice Guide applicable for AIMDD, MDD, and IVDD 2009-4 Guidance on Notified Body s Tasks of Technical Documentation Assessment on a Representative Basis 1 Introduction The Directive 93/42/EEC
The Industry in Korea: Strategies Seth J. Goldenberg, Senior Principal Scientist, NAMSA; Yongha Na, Director, Medipert Regulatory NAMSA Whitepaper #09 06/2014 Seth J. Goldenberg, PhD (email@example.com)
Temple University - School of Pharmacy 425 Commerce Drive, Suite 175 Fort Washington, PA 19034 Phone: 267.468.8560 Fax: 267.468.8565 CERTIFICATE IN BASIC PHARMACEUTICAL DEVELOPMENT Focusing on the Business
eskbook Emerging Life Sciences Companies second edition Chapter 30 Issues That Must Be Addressed in a Life Sciences M&A Chapter 30 ISSUES THAT MUST BE ADDRESSED IN A LIFE SCIENCES M&A As demonstrated in
Contract Research and Consulting Organisation Consulting Clinical Trial Operations Training Your partner for CLINically remarkable results We are a leading Polish company specializing in clinical research
CATEGORY Advertising Guidance Agenda: New & Guidances CDER is Planning to Publish During Calendar Year 2016 (See the Good Guidance Practices (GGPs) regulation on this Web page or 21 CFR 10.115 for details
21 December 2015 EMA/INS/GMP/738756/2015 Compliance and Inspection Work plan for GMP/GDP Inspectors Working Group for 2016 Chairperson: Status David Cockburn January 2016 1. Meetings scheduled for 2016
The Regulation of Medical Device Apps Prepared for West of England Academic Health Science Network and University of Bristol June 2014 June 2014 1 Table of Contents 1 Purpose...3 2 Scope...3 3 The Regulation
Health Products and Food Branch 1 HEALTH CANADA PART C DIVISION 5 - DRUGS FOR CLINICAL TRIALS INVOLVING HUMAN SUBJECTS Part C - Division 5 2 Part A: Part B: Part C: Part D: Part E: Part G: Part J: Administration
MEDICAL DEVICE Communiqué JANUARY 2013 Making the Case... 2 The FDA s Focus on Quality.......... 2 Facilitating Entry to Global Markets... 3 The FDA Makes a Case for Quality Globalization Risks and Rewards...